Health News

(University of Montreal) Canadian researchers have identified a new protein in the progression of breast cancer. According to a recent study from the Universite de Montreal and the University of Alberta, published in the Journal of Biological Chemistry, the protein ARF1 plays a critical role in cancer cell growth and the spread of tumors. Targeting this protein with drug therapy may provide hope to women with breast cancer.

Read more

Filed under: General Health News
Tags: Breast Cancer, cancer, Drug, General Health News, Protein, Tumor

Related posts

• Therapy targeting cyclin D1 protein may block expansion of breast cancer cells (0)
  Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. Read more [tags] General Health News [/tags]
  
  
• Therapy may block expansion of breast cancer cells (0)
  (Wiley-Blackwell) Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational Science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion [...]
  
  
• PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study (0)
  Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group investigators. Read more [tags] Pharmacy News [/tags]
  
  
• Early-stage breast cancer patients with HER2 positive tumors at increased risk of recurrence (0)
  Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center. Read more [tags] General Health News [...]
  
  
• Compounds could be new class of cancer drugs (0)
  (Vanderbilt University Medical Center) A team of Vanderbilt University Medical Center investigators has developed a group of chemical compounds -- the first selective inhibitors of the protein phospholipase D -- that could represent a new class of drugs for treating cancer.The new inhibitors, reported in the February issue of Nature Chemical Biology, block the invasive [...]